Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03978312
Other study ID # 18ON105
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date September 1, 2019
Est. completion date March 31, 2020

Study information

Verified date March 2022
Source Nottingham University Hospitals NHS Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

An exploration of the impact of nutrition literacy on ability of cancer patients and their support networks to get, understand and use nutrition information during cancer treatment.


Description:

The study is composed of two component projects: Project A: Validation of a NLit tool for UK population. NLit tool is a measurement tool developed at Kansas University to measure nutrition health literacy. It assesses the following functional literacy skills: numeracy & literacy and the following nutrition knowledge fields: macronutrients, food labels, portion sizes, food groups and consumer skills. This project has two phases: Phase A: Nominal consensus groups x 2 - consumer adaptation and tool review for UK use and pilot testing of electronic tool. Phase B: Testing adapted tool in a group of cancer patients for statistical validation. Project B: Planned survey of people with cancer and their families to explore experiences of access to nutrition information This survey is a combination of validated and unvalidated questions built on models of nutrition health literacy. With validated fields being used to evaluate and understand responses to unvalidated questions. It explores access to nutrition information, self-efficacy, confidence, health care infrastructure and support with nutrition information, population demographics, food security, sources of nutrition information, perceived practical skills and knowledge base.


Recruitment information / eligibility

Status Terminated
Enrollment 58
Est. completion date March 31, 2020
Est. primary completion date March 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility NLit-UK development Inclusion Criteria: - Members of the public (carers, health service users, lay persons) - Cancer patients with confirmed diagnosis - Friends or family members supporting a patient with a confirmed diagnosis of cancer - > 18 yrs old - Received cancer treatment at Nottingham University Hospitals between Jan 15 and March 20 Exclusion Criteria: - Paediatrics < 18yrs at the time of diagnosis and treatment - Unconfirmed diagnosis of cancer - Patients on watch and wait

Study Design


Intervention

Other:
Nominal consensus group
NLit-UK linguistic and cultural adaptation (NLit-UK) 2 x nominal consensus groups evidence review and topic expert engagement
Observational cohort (validity and reliability testing)
Nutrition Literacy Measurement Tool validation (NLit-UK). Target sample 366 on treatment cancer patients confirmatory binary analysis for validity and reliability.

Locations

Country Name City State
United Kingdom Nottingham University Hospitals NHS Trust Nottingham Nottinghamshire

Sponsors (5)

Lead Sponsor Collaborator
Nottingham University Hospitals NHS Trust Bishop Grosseteste University, Macmillan Cancer Support, Newcastle University, University of Kansas

Country where clinical trial is conducted

United Kingdom, 

References & Publications (3)

Gibbs HD, Ellerbeck EF, Befort C, Gajewski B, Kennett AR, Yu Q, Christifano D, Sullivan DK. Measuring Nutrition Literacy in Breast Cancer Patients: Development of a Novel Instrument. J Cancer Educ. 2016 Sep;31(3):493-9. doi: 10.1007/s13187-015-0851-y. — View Citation

Gibbs HD, Ellerbeck EF, Gajewski B, Zhang C, Sullivan DK. The Nutrition Literacy Assessment Instrument is a Valid and Reliable Measure of Nutrition Literacy in Adults with Chronic Disease. J Nutr Educ Behav. 2018 Mar;50(3):247-257.e1. doi: 10.1016/j.jneb.2017.10.008. Epub 2017 Dec 12. — View Citation

Gibbs HD, Harvey S, Owens S, Boyle D, Sullivan DK. Engaging Experts and Patients to Refine the Nutrition Literacy Assessment Instrument. BMC Nutr. 2017;3:71. doi: 10.1186/s40795-017-0190-y. Epub 2017 Aug 22. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Nutrition health literacy - UK Measured by UK modified NLit developed during study cultural and linguistic modification of (Gibbs et al., 2018 - original validation) - 64 item questionnaire
Scoring interpretation from study: NLit-UK (63item) and NLit-UK short (42-item) NLit-UK (63-item): Scoring interpretation is =44 correct is "likelihood of poor nutrition literacy"; 45-57 is "possibility of poor nutrition literacy"; and scores =58 is "likelihood of good nutrition literacy
NLit-UK short (42-item): Scoring interpretation is =28 correct is "likelihood of poor nutrition literacy"; 29-37 is "possibility of poor nutrition literacy"; and scores =39 is "likelihood of good nutrition literacy
Jun 19 - Mar 2020
Primary NVS-UK health literacy Validated tool - 6 part question (Rowlands et al, 2013)
Scoring interpretation: low health literacy (=1), intermediate health literacy (2-3), adequate health literacy (=4).
Jun 19 - Mar 2020
Secondary Prior Knowledge Did you receive any nutrition advice as part of your care for any of these conditions?" (Yes or No). Jun 19 - Mar 2020
Secondary Educational status (modified HINTS4 Cyc1) What is the highest grade or level of schooling you completed? GCSE D or less/ GCSE C or above/ Unsure Jun 19 - Mar 2020
Secondary Economic status (modified HINTS 2) At the end of the month, how much money are you able to put aside? (Nothing, £100 or less, £101-250, £251-500, £501-1000, more than £1000, do not want to say). Jun 19 - Mar 2020
Secondary How important did you consider nutrition was in helping you through your treatment? Response sets: Didn't know enough to consider / Not important ; Moderately Important; Very or extremely important Jun 19 - Mar 2020
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases